Teva Pharmaceuticals
TEVA
TEVA
441 hedge funds and large institutions have $5.05B invested in Teva Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 127 increasing their positions, 148 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
26% less call options, than puts
Call options by funds: $177M | Put options by funds: $240M
29% less capital invested
Capital invested by funds: $7.13B → $5.05B (-$2.08B)
58% less funds holding in top 10
Funds holding in top 10: 12 → 5 (-7)
Holders
441
Holding in Top 10
5
Calls
$177M
Puts
$240M
Top Buyers
| 1 | +$84.5M | |
| 2 | +$37.2M | |
| 3 | +$26.2M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$22.5M |
| 5 |
EP
Eversept Partners
New York
|
+$21.6M |
Top Sellers
| 1 | -$73.3M | |
| 2 | -$63.8M | |
| 3 | -$41.3M | |
| 4 |
MIFH
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
|
-$39.5M |
| 5 |
NC
Noked Capital
Tel Aviv,
Israel
|
-$36.5M |